NCT06456528
- Conditions
- Cancer Treatment-induced Thrombocytopenia
- Locations
-
- Harbin First Hospital Harbin, China
- Nanjing Tianyinshan Hospital Nanjing, China
Clinical trial condition
Explore clinical trials studying Cancer Treatment-induced Thrombocytopenia. Study availability and eligibility vary by location and protocol.
NCT06456528
NCT07441720